Suchergebnisse - "Kuliopulos, Athan"

PubPharm (136)

1

Suppression of Heart Failure With PAR1 Pepducin Technology in a Pressure Overload Model in Mice

enthalten in: Circulation. Heart failure | 2023

von Fletcher, E. | Ngwenyama, N. | Nguyen, N. | +4

2

METHODS AND COMPOSITIONS FOR PROVIDING MYOCARDIAL PROTECTION AND TREATING MYOCARDIAL STRESS AND FIBROSIS

enthalten in: Europäisches Patentamt | 2023

von KULIOPULOS ATHAN | COVIC LIDIJA

3

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Abdelmalek, M. | Covic, L. | Kuliopulos, A.

4

PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference

enthalten in: Hepatology (Baltimore, Md.) | 2022

von Shearer, A. | Wang, Y. | Fletcher, E. | +6

CommentIn: Hepatology. 2023 May 1;77(5):E109-E110. - PMID 36869844

5

Lipopeptide Pepducins as Therapeutic Agents

enthalten in: Methods in molecular biology (Clifton, N.J.) | 2022

von Michael, E. | Covic, L. | Kuliopulos, A.

6

PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference

enthalten in: Hepatology | 2022

von Shearer, A. | Wang, Y. | Fletcher, E. | +6

7

Deficiency of MMP1a (Matrix Metalloprotease 1a) Collagenase Suppresses Development of Atherosclerosis in Mice : Translational Implications for Human Coronary Artery Disease

enthalten in: Arteriosclerosis, thrombosis, and vascular biology | 2021

von Fletcher, E. | Wang, Y. | Flynn, L. | +7

8

PEPDUCIN DESIGN AND USE

enthalten in: Europäisches Patentamt | 2021

von KULIOPULOS ATHAN | COVIC LIDIJA

9

Pepducin design and use

enthalten in: Europäisches Patentamt | 2021

von KULIOPULOS ATHAN | COVIC LIDIJA

10

PAR-1 Activation by Metalloproteinase-1 (MMP-1)

enthalten in: Europäisches Patentamt | 2021

von KULIOPULOS ATHAN | KOUKOS GEORGIOS

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]